# Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer

> **NCT00985738** · PHASE2 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 16 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Dutasteride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00985738
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2016-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00985738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00985738, "Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00985738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*